In particular, CD4+ CXCR5+ Tfh cells have been confirmed to manipulate the levels of estimated glomerular filtration rate (GFR), creatinine, urea, urinary protein, fasting and postprandial blood glucose, and hemoglobin A1c in patients with DKD (55). This evidence concerns the gene CXCR5 and diabetic kidney disease.